Skip to main content
. 2024 Mar 18;331(13):1122–1134. doi: 10.1001/jama.2024.2424

Table 1. Demographic and Clinical Characteristics of Participants in the Neuroimaging Study.

Characteristic No. (%)
Anomalous health incidents Present before anomalous health incidenta Present during or after anomalous health incidenta US government control participants NIH control participants
No. 81 29 19
Age, mean (SD), y 42.0 (9.1) 44 (10.1) 41 (12.7)
Sex, No. (%)
Female 40 (49) 10 (34) 10 (53)
Male 41 (51) 19 (66) 9 (47)
Education from first grade, mean (SD), y 17.0 (1.9) 17.8 (1.9) 17 (2.0)
US government employee family member 10 (12) NA NA
Reduced capacity and/or unable to work due to anomalous health incidents 25 (31)
Time from first incident to research MRI acquisition, median (range), d 80 (14-1505) NA NA
Sound or pressure 70 (86) NA NA
Directionality and/or locality 57 (66) NA NA
Symptoms
Headache 33 (38) 60 (70) 12 (41) 11 (58)
Sleep dysfunction 11 (17) 47 (60) 1 (3) 3 (16)
Depression 11 (14)b 18 (22)b 0c 1 (5)c
Vision changes 9 (11) 30 (37) 0 0
Posttraumatic stress disorder 7 (9)b 7 (9)b 0b 0c
Imbalance 4 (5) 43 (53) 0 1 (5)
Cognitive 1 (1) 55 (64) 0 0
Dizziness 1 (1) 32 (37) 0 0
Diagnoses
Migraine headache 22 (27) 32 (39) 2 (7) 4 (21)
Tinnitus 13 (16) 45 (55) 0 0
Peripheral neuropathy 9 (11) 11 (14) 0 0
Cranial neuropathy 5 (6) 6 (7) 0 0
Headache, unspecified 4 (5) 13 (16) 12 (41) 6 (32)
Cancer 3 (4) 5 (6) 0 0
Strabismus 2 (2) 3 (4) 0 0
Seizure disorder 1 (1) 1 (1) 1 (3) 0
Functional neurologic disorder 1 (1) 20 (25) 0 0
New daily persistent headache 0 20 (25) 0 0
Current cataract 1 (1) 21 (26) 0 1 (5)
Benign paroxysmal positional vertigo 1 (1) 3 (4) 0 0
Tension-type headache 0 2 (2) 0 0

Abbreviations: NA, not applicable; NIH, National Institutes of Health.

a

Data in these columns are not mutually exclusive. If a patient had symptoms or diagnoses before the anomalous health indecent and continued to have it after the anomalous health incident, they are counted in both columns.

b

Based on history and physical examination.

c

NIH control participants were administered the Posttraumatic Stress Disorder Checklist—Civilian and a cutoff of greater than 29 was used to indicate clinically significant posttraumatic stress disorder symptoms (https://www.ptsd.va.gov/professional/assessment/documents/PCL_handoutDSM4.pdf).